Approval · Notice of Compliance 32397 · 2023
HALOPERIDOL INJECTION: Notice of Compliance 32397
Issued December 21, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32397
- Date
- December 21, 2023
- Company
- Omega Laboratories LimitedMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph. Update to the Package Insert. Update to Labels
- Canadian reference product
- HALOPERIDOL INJECTION USP (Sandoz Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALOPERIDOL INJECTION | Not yet assigned | — |
Medicinal ingredients
- HALOPERIDOL 5 MG per ML